Who invested in Anaheim Bio?
Anaheim Bio's investors include Novartis Venture Fund, RTW Investments LLC, Thuja Capital, Frazier Life Sciences and Droia Ventures, and 1 more on record.
Netherlands · Series A startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised this month
Follow Anaheim Bio and see its new rounds in your feed. Start following
Funding summaryUpdated 7 Nov 2026
$45Mraised across 1 round since 2026, from 5 sources
Reported by BeBeez International and 4 others
Anaheim Bio's investors include Novartis Venture Fund, RTW Investments LLC, Thuja Capital, Frazier Life Sciences and Droia Ventures, and 1 more on record.
Anaheim Bio has raised $45M across 1 round since 2026.
Anaheim Bio's most recent round was a Series A of $45M in Nov 2026.
Its most recent round, $45M in Nov 2026, is also its largest on record.
Anaheim Bio's first round on record, in Nov 2026, was backed by Novartis Venture Fund, RTW Investments LLC and Thuja Capital and 3 others.
Anaheim Bio's latest named round is a Series A, in Nov 2026.
Anaheim Bio is based in the Netherlands.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.